Summary
The effect of milk and food on the pharmacokinetics of estramustine phosphate was investigated in six patients with prostatic cancer. In a randomized three-way cross-over study, the patients were given single doses of the drug together with low calcium water, low calcium food and milk. The evaluation was based upon the plasma concentration of two metabolites, estromustine and estrone, as parent drug could not be detected in plasma.
The tmax and lag time of estromustine were significantly increased by milk and food intake and Cmax and AUC were significantly decreased. In comparison with water, the AUC of estromustine was 41% when the drug was taken with milk and 67% after simultaneous intake of standardized food. Corresponding figures for the peak values were 32 and 57%, respectively. The effect of milk and food intake on the pharmacokinetics of estrone was similar.
Studies in vitro demonstrated that the dissolution of estramustine phosphate disodium was markedly impaired in the presence of calcium. It was concluded that the rate and extent of absorption of estramustine phosphate were decreased when the drug was taken with milk or food due to the formation of a poorly absorbable calcium complex. To obtain high and reproducible absorption of Estracyt®, the drug should not be taken together with milk, milk products or other calcium-rich food or drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Toothaker RD, Welling PG (1980) The effect of food on drug bioavailability. Ann Rev Pharmacol Toxicol 20: 173–199
Melander A, Lalka D, McLean A (1988) Influence of food on the presystemic metabolism of drugs. Pharmacol Ther 38: 253–267
D'Arcy PF, McElnay JC (1985) Drug interactions in the gut involving metal ions. Rev Drug Metabol Drug Interact 5: 83–112
Andersson KE (1988) Influence of diet and nutrition on clinical pharmacokinetics. Clin Pharmacokinet 14: 325–346
Ekstrand J, Ehrnebo M (1979) Influence of milk products on fluoride bioavailability in man. Eur J Clin Pharmacol 16: 211–215
Pinkerton CR, Glasgow JFT, Welsman SG, Bridges JM (1980) Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia? Lancet I: 944–945
Höisaeter P, Bakke A (1983) Estramustine phosphate (Estracyt): experimental and clinical studies in Europe. Semin Oncol 10 [Suppl 3]: 27–33
Hedlund PO (1987) Estracyt — mode of action and clinical experience. In: prostate cancer, part B: imagine techniques radiotherapy, chemotherapy and management issues. Liss, New York, pp215–219
Gunnarsson PO, Andersson S-B, Johansson S-Å, Nilsson T, Plym-Forshell G (1984) Pharmacokinetics of estramustine phosphate (Estracyt®) in prostatic cancer patients. Eur J Clin Pharmacol 26: 113–119
Hartley-Asp B (1984) Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3. Prostate 5: 93–100
Norlén BJ, Andersson S-B, Björk P, Gunnarsson PO, Fritjofsson Å (1988) Uptake of estramustine phosphate (Estracyt) metabolites in prostatic cancer. J Urol 140: 1058–1062
Forsgren B, Gunnarsson PO, Johansson S-Å, Kant R (1978) Radioimmunoassay of estramustine phosphate in plasma. Acta Pharm Suec 15: 200–210
Andersson S-B, Lundgren R, Svensson L (1982) Gas chromatographic determination of four metabolites of estramustine phosphate in plasma. Acta Pharm Suec 19: 1–10
The United States Pharmacopeia XXI 1985; 1244
Gunnarsson PO, Andersson S-B, Johansson S-Å (1983) The hydrolysis of estramustine phosphate; in vitro studies. Eur J Drug Metabol Pharmacokinet 4: 395–402
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gunnarsson, P.O., Davidsson, T., Andersson, SB. et al. Impairment of estramustine phosphate absorption by concurrent intake of milk and food. Eur J Clin Pharmacol 38, 189–193 (1990). https://doi.org/10.1007/BF00265983
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00265983